SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: muddphudd who wrote (1781)6/1/2001 7:53:36 PM
From: vestor  Read Replies (1) of 1837
 
Frankly, I have lost faith in the anlaysts. Conflicts of interest abound. However they are useful in introducing DRMD to their institutional customers. I think the two presentations that DRMD just did has resulted in interest in the stock by serious money. Some big blocks were bought recently.

I do expect that they will be permitted to go generic on that BTGC drug in the next few weeks and that will push DRMD into the mid to high teens.

I think one would not want to miss the day that DRMD announces they go from 20/80 with Solvay to 80/20. I expect a good $5. to $10. pop. I just wish I knew when it will occur.

It is great that the CEO is out there talking of DRMD and its product line. I hope this goes on. trust he see's the benefit.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News